X

pharmaceuticals

“Gelteq has been continuously evolving to expand applications and audiences”

Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a…

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025.…

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer…

Earnings Summary: Baxter International reports higher sales for Q3 2024

Medical device maker Baxter International Inc. (NYSE: BAX) announced financial results for the third quarter of 2024, reporting a modest…

Earnings Summary: Moderna swings to profit in Q3 on modest revenue growth

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported net income for the third quarter of 2024, compared to a loss…

Earnings Summary: Everything you need to know about Cardinal Health’s Q1 report

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Friday reported an increase in adjusted profit for the first quarter…

Infographic: How Merck (MRK) performed in Q3 2024

Merck (NYSE: MRK) reported its third quarter 2024 earnings results today. Sales grew 4% year-over-year to $16.7 billion. Excluding FX,…

Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights

Eli Lilly and Company (NYSE: LLY) reported its third quarter 2024 earnings results today. Worldwide revenue was $11.44 billion, up…

Key takeaways from Pfizer’s (PFE) Q3 2024 earnings report

Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday, despite the company delivering better-than-expected earnings results for…

PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results

Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today. Revenues increased 31% year-over-year to $17.7 billion. Revenues…

Earnings Summary: HCA Healthcare reports Q3 2024 financial results

Hospital operator HCA Healthcare, Inc. (NYSE: HCA) on Friday announced financial and operating results for the third quarter ended September…

Earnings Summary: Everything you need to know about Centene’s Q3 report

Healthcare service provider Centene Corporation (NYSE: CNC) announced third-quarter 2024 results, reporting higher revenue and a decline in adjusted profit.…

Intuitive Surgical (ISRG) reports double-digit growth in Q3 revenue and earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a sharp increase in earnings for the third quarter of…

Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights

Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today. Reported sales increased 5.2% year-over-year to $22.5 billion.…

Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode

Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its…

Walgreens Boots Alliance’s Q4 results likely to reflect market challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due…

IPO News: Everything you need to know about BioAge Labs’ IPO

BioAge Labs, Inc. is the latest among the healthcare companies pursuing stock-market listing this year. In a registration statement filed…

Guardian Pharmacy seeks to raise up to $108 mil in US IPO

Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to…

Everything you need to know about Zenas BioPharma’s IPO

Zenas BioPharma, Inc. is among the latest healthcare companies to jump on the IPO bandwagon, filing its prospectus even as…

Medtronic bets on innovation and new technology to drive long-term growth

Over the years, Medtronic plc (NYSE: MDT) has constantly strengthened its position in the medical device industry by innovating the…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the…